Up Next
Back to Show
PBS News Hour
Why FDA approval of sickle cell gene therapy is a ‘big deal’
Sickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that uses the gene-editing tool CRISPR. John Yang speaks with Yale School of Medicine assistant professor Dr. Cece Calhoun and New York Times reporter Gina Kolata to learn more.
Support Provided By
57:46
January 30, 2026 - PBS News Hour full episode
57:46
January 29, 2026 - PBS News Hour full episode
57:46
January 28, 2026 - PBS News Hour full episode
57:46
January 23, 2026 - PBS News Hour full episode
57:46
January 27, 2026 - PBS News Hour full episode
57:46
January 22, 2026 - PBS News Hour full episode
57:46
January 26, 2026 - PBS News Hour full episode
57:46
January 21, 2026 - PBS News Hour full episode
57:46
January 20, 2026 - PBS News Hour full episode
57:46
January 19, 2026 - PBS News Hour full episode
57:46
January 16, 2026 - PBS News Hour full episode
56:46
January 15, 2026 - PBS News Hour full episode